UASt regulatory sequences drive expression of an inverted repeat.
The expression of wunGD1640 under the control of Scer\GAL4c564 has no obvious affect on the inflammatory response to Gram-positive bacterial infection, but leads to a minor ectopic inflammatory response in basal (non-infected) conditions, as compared to controls.
Adults expressing wunGD1640 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.
wunGD1640, Scer\GAL4Act.PU is a suppressor of abnormal locomotor behavior phenotype of DysRNAi.NH2.UAS, Scer\GAL4Act.PU
wunGD1640, Scer\GAL4Tub.PU is a suppressor of abnormal locomotor behavior phenotype of DysRNAi.C.UAS, Scer\GAL4Tub.PU
wunGD1640/Scer\GAL4r4 is a non-suppressor of decreased size | larval stage phenotype of TorsinKO78
wunGD1640, Scer\GAL4Tub.PU is a suppressor of indirect flight muscle cell phenotype of DysRNAi.C.UAS, Scer\GAL4Tub.PU
wunGD1640, Scer\GAL4Tub.PU is a suppressor of myofibril phenotype of DysRNAi.C.UAS, Scer\GAL4Tub.PU
wunGD1640/Scer\GAL4r4 is a non-suppressor of embryonic/larval fat body | larval stage phenotype of TorsinKO78
Expression of wunGD1640 suppresses the defects in indirect flight muscle myofibril integrity seen when DysdsRNA.C.Scer\UAS is expressed under the control of Scer\GAL4tub.PU. The reduction in activity levels is also suppressed.
Expression of wunGD1640 suppresses the reduction in activity levels seen when DysdsRNA.NH2.Scer\UAS is expressed under the control of Scer\GAL4Act.PU.